Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges - Quiz - MDSpire

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

  • By

  • Shuyu Ren

  • Fangfang Pan

  • Jie Jin

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

  • by Shuyu Ren, Fangfang Pan, Jie Jin

  • May 14, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation